Surgical Strategies for Prevention and Treatment of Lymphedema in Breast Cancer Patients

Daniela Ochoa, Vicki Klimberg

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The evidence available for risk reduction of lymphedema after breast cancer treatment is sparse and inconsistent. It is limited by confounding factors such as axillary disease burden, number of lymph nodes harvested, and radiation treatment. However, there are several strategies for prevention and risk reduction prior to the onset of lymphedema. Techniques such as sentinel lymph node biopsy, axillary reverse mapping, lymphatic anastomosis, and lymphovenular anastomosis are aimed at preventing or minimizing the disruption of lymphatic flow from the upper extremity. Few surgical procedures, such as the historical Charles procedure, as well as newer techniques including distal lymphaticovenular anastomosis, lymph node transfer, suction-assisted protein lipectomy, and low-level laser therapy exist. Nonsurgical treatments include complete decongestive therapy, pneumatic compression, Kinesio tape, and exercise. These have varying degrees of effectiveness but have limitations in patient compliance or availability of certified therapists.

Original languageEnglish (US)
JournalCurrent Breast Cancer Reports
Volume7
Issue number1
DOIs
StatePublished - Mar 28 2015
Externally publishedYes

Fingerprint

Risk Reduction Behavior
Lymph Nodes
Lipectomy
Sentinel Lymph Node Biopsy
Lymphedema
Suction
Therapeutics
Patient Compliance
Upper Extremity
Exercise
Radiation
Breast Cancer Lymphedema
Proteins
Low-Level Light Therapy

Keywords

  • Axillary dissection
  • Axillary reverse mapping
  • Breast cancer
  • Lymph nodes
  • Lymphadenectomy
  • Lymphedema
  • Sentinel

ASJC Scopus subject areas

  • Oncology

Cite this

Surgical Strategies for Prevention and Treatment of Lymphedema in Breast Cancer Patients. / Ochoa, Daniela; Klimberg, Vicki.

In: Current Breast Cancer Reports, Vol. 7, No. 1, 28.03.2015.

Research output: Contribution to journalReview article

@article{c70cc6f5a9fc4023bd3bcfea05b9c813,
title = "Surgical Strategies for Prevention and Treatment of Lymphedema in Breast Cancer Patients",
abstract = "The evidence available for risk reduction of lymphedema after breast cancer treatment is sparse and inconsistent. It is limited by confounding factors such as axillary disease burden, number of lymph nodes harvested, and radiation treatment. However, there are several strategies for prevention and risk reduction prior to the onset of lymphedema. Techniques such as sentinel lymph node biopsy, axillary reverse mapping, lymphatic anastomosis, and lymphovenular anastomosis are aimed at preventing or minimizing the disruption of lymphatic flow from the upper extremity. Few surgical procedures, such as the historical Charles procedure, as well as newer techniques including distal lymphaticovenular anastomosis, lymph node transfer, suction-assisted protein lipectomy, and low-level laser therapy exist. Nonsurgical treatments include complete decongestive therapy, pneumatic compression, Kinesio tape, and exercise. These have varying degrees of effectiveness but have limitations in patient compliance or availability of certified therapists.",
keywords = "Axillary dissection, Axillary reverse mapping, Breast cancer, Lymph nodes, Lymphadenectomy, Lymphedema, Sentinel",
author = "Daniela Ochoa and Vicki Klimberg",
year = "2015",
month = "3",
day = "28",
doi = "10.1007/s12609-014-0172-x",
language = "English (US)",
volume = "7",
journal = "Current Breast Cancer Reports",
issn = "1943-4588",
publisher = "Current Science, Inc.",
number = "1",

}

TY - JOUR

T1 - Surgical Strategies for Prevention and Treatment of Lymphedema in Breast Cancer Patients

AU - Ochoa, Daniela

AU - Klimberg, Vicki

PY - 2015/3/28

Y1 - 2015/3/28

N2 - The evidence available for risk reduction of lymphedema after breast cancer treatment is sparse and inconsistent. It is limited by confounding factors such as axillary disease burden, number of lymph nodes harvested, and radiation treatment. However, there are several strategies for prevention and risk reduction prior to the onset of lymphedema. Techniques such as sentinel lymph node biopsy, axillary reverse mapping, lymphatic anastomosis, and lymphovenular anastomosis are aimed at preventing or minimizing the disruption of lymphatic flow from the upper extremity. Few surgical procedures, such as the historical Charles procedure, as well as newer techniques including distal lymphaticovenular anastomosis, lymph node transfer, suction-assisted protein lipectomy, and low-level laser therapy exist. Nonsurgical treatments include complete decongestive therapy, pneumatic compression, Kinesio tape, and exercise. These have varying degrees of effectiveness but have limitations in patient compliance or availability of certified therapists.

AB - The evidence available for risk reduction of lymphedema after breast cancer treatment is sparse and inconsistent. It is limited by confounding factors such as axillary disease burden, number of lymph nodes harvested, and radiation treatment. However, there are several strategies for prevention and risk reduction prior to the onset of lymphedema. Techniques such as sentinel lymph node biopsy, axillary reverse mapping, lymphatic anastomosis, and lymphovenular anastomosis are aimed at preventing or minimizing the disruption of lymphatic flow from the upper extremity. Few surgical procedures, such as the historical Charles procedure, as well as newer techniques including distal lymphaticovenular anastomosis, lymph node transfer, suction-assisted protein lipectomy, and low-level laser therapy exist. Nonsurgical treatments include complete decongestive therapy, pneumatic compression, Kinesio tape, and exercise. These have varying degrees of effectiveness but have limitations in patient compliance or availability of certified therapists.

KW - Axillary dissection

KW - Axillary reverse mapping

KW - Breast cancer

KW - Lymph nodes

KW - Lymphadenectomy

KW - Lymphedema

KW - Sentinel

UR - http://www.scopus.com/inward/record.url?scp=84938951430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938951430&partnerID=8YFLogxK

U2 - 10.1007/s12609-014-0172-x

DO - 10.1007/s12609-014-0172-x

M3 - Review article

AN - SCOPUS:84938951430

VL - 7

JO - Current Breast Cancer Reports

JF - Current Breast Cancer Reports

SN - 1943-4588

IS - 1

ER -